{"id":"NCT01618695","sponsor":"Eisai Co., Ltd.","briefTitle":"A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures","officialTitle":"A Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-05-15","primaryCompletion":"2014-09-15","completion":"2020-05-28","firstPosted":"2012-06-13","resultsPosted":"2020-06-05","lastUpdate":"2021-07-29"},"enrollment":940,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Partial-onset Seizures"],"interventions":[{"type":"DRUG","name":"Perampanel","otherNames":["E2007"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Perampanel","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to confirm the efficacy and safety of perampanel compared to placebo in patients with refractory partial-onset seizures","primaryOutcome":{"measure":"Core Phase: Percent Change in Seizure Frequency (For All Partial Seizures) Per 28 Days in the Randomization Phase Relative to Pre-randomization Phase (Baseline)","timeFrame":"Baseline, Week 19","effectByArm":[{"arm":"Placebo","deltaMin":-10.76,"sd":null},{"arm":"Perampanel 4 mg","deltaMin":-17.32,"sd":null},{"arm":"Perampanel 8 mg","deltaMin":-28.95,"sd":null},{"arm":"Perampanel 12 mg","deltaMin":-38.03,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.2330"},{"comp":"OG000 vs OG002","p":"0.0003"},{"comp":"OG000 vs OG003","p":"<0.0001"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":117,"countries":["Australia","China","Japan","Malaysia","South Korea","Taiwan","Thailand"]},"refs":{"pmids":["37059702","29250772"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":176},"commonTop":["Dizziness","Somnolence","Nasopharyngitis","Headache","Upper respiratory tract infection"]}}